Bioprocessing without limits. Anytime. Anywhere.

Introducing Stratyx™, the first mobile, cloud-integrated, laboratory bioreactor designed for flexibility, automation, and scalability. Whether you're focused on early-stage research or preparing your team for bioreactor scale up, our Stratyx bioreactor system provides unmatched control and visibility into every stage of your process development.

Units now available with early adopter pricing + free consumables + free Console license

Set Up Your Process

Configure in Culture Console™

Auto-Fill Consumables

Automated syringe preparation

Run & Monitor Remotely

Access real-time data from anywhere, anytime

Analyze & Optimize

Work with Culture Bio experts for experiment and process design

Protect Your Data

Data is saved in real-time, even if connection is lost

Stratyx™ 250 Process Development Bioreactor

Accessories

Auto Filler
Automates syringe preparation for consistent media feed
Consumables
QR-code integration ensures seamless tracking and inventory management
Culture Console License
Unlocks full access to experimental design, execution and monitoring through our cloud-based platform

The ‘Cultured’ Advantage

The Stratyx™ 250 laboratory bioreactor sets a new standard for modular bioreactor platforms, delivering superior performance and cost efficiency compared to traditional and first-generation modular systems. Engineered to provide you with the data you need for bioreactor scale up, Stratyx helps streamline your transition from benchtop to pilot production.

Cost Per Run
Time Savings
Scale-Up Success
Mobility & Flexibility
Cloud Integration
Setup & Cleaning
Support & expertise
Stratyx™ 250
16% lower total cost savings
>10-hour reduction in FTE time
30% better success rates
Cart-based, easily movable
Remote monitoring and automation
Single-use, no validation required
Direct access to Culture Bio’s team & bioreactor fleet
Traditional Benchtop Bioreactors
Higher operational costs
Higher manual workload
Limited scalability
Fixed placement
No native cloud support
Requires cleaning & validation
Standard support
Microbioreactor Systems
Expensive for small research teams
Requires more setup time
Less representative scale-down models
Some modularity
Limited cloud connectivity
Some disposable components
Moderate support, but costly

Powered by Console | The Future of Bioreactor Systems

Stratyx™ is powered by Culture Console, a seamlessly integrated cloud-based bioreactor system that optimizes performance, experiment management, and data analytics. Accessible anytime, anywhere.

One interface

Our secure web application, Console, serves as a hub to manage all of your cell culture experiments, data, and insights.

Analytics tools

We offer analysis tools, real-time monitoring, and modality-specific assays to help you gather the insights you need.

Remote collaboration

Our cloud-based architecture enables you to access data and collaborate from anywhere.

Real-time data access

Monitor and control your laboratory bioreactor as if it were running right next to you.

“Stratyx™ 250 is already reshaping how we approach process development. The ability to remotely monitor and adjust experiments in real time is streamlining our workflows and improving reproducibility across runs. The combination of cloud integration, automation, and mobility makes it a game-changer for modern bioprocessing.”

Jondavid De Jong, PhD

Stratyx™ 250 FAQs

What is included in the system?

Bioreactor Units, Utility Cart, Bay Carts, Console Software, Autofiller, Chiller

What are the space and utility requirements?

Power: 120V, 20A circuit, CAT6 ethernet, Lab Space (linear configuration): 4-bay system: 68” × 46” footprint, Gas inlets: for Air, N₂, O₂, CO₂.

What are the scalability options for the Stratyx™ 250?

Our vessels are well characterized for kLa and P/V. We offer seamless scaling to Cytiva Xcellerex and XDR platforms as well as other reactors.

What types of cell cultures can the Stratyx™ 250 support?

Our equipment supports HEK and CHO, batch and fed-batch cell culture processes with future expansions planned to support additional cell types.